n | 10 | 14 | | 61 | 10 | |
Sex (M/F) | 5/5 | 7/7 | >0.10 | 31/30 | 5/5 | >0.10 |
Age at implantation (years) | 1.4 (1.1) | 1.5 (1.1) | >0.10 | 15.0 (5.1) | 9.7 (7.5) | <0.05 |
Weight at implantation (kg) | 10.3 (4.5) | 8.5 (3.8) | >0.10 | 41.8 (18.5) | 27.0 (15.7) | <0.02 |
Follow up (years) | 2.0 (1.0) | 2.4 (2.2) | >0.10 | 2.1 (1.9) | 2.8 (1.3) | >0.10 |
|
Indication
| | | | | | |
Postoperative block | 4 (40%) | 4 (29%) | >0.10 | 25 (41%) | 8 (80%) | >0.10 |
CCAVB | 5 (50%) | 7 (50%) | >0.10 | 24 (39%) | 1 (10%) | >0.10 |
2nd Degree block | 0 | 3 (21%) | <0.012 | 0 | 0 | |
Sinus node dysfunction | 0 | 0 | | 9 (15%) | 1 (10%) | >0.10 |
Long QT syndrome | 1 (10%) | 0 | >0.10 | 1 (2%) | 1 (10%) | >0.10 |
Cardiac arrest | 0 | 0 | | 2 (3%) | 0 | >0.10 |